Assessing hemorrhagic risks in combination therapy: implications of angiogenesis inhibitors and immune checkpoint inhibitors

Authors: Yuhui Yang, Pingping Long, Ying Tuo, Xiaoxiao Wang

Source: Frontiers in Immunology, Vol 16 (2025)

Subject Terms: immune checkpoint inhibitors, angiogenesis inhibitors, FDA adverse event reporting system (FAERS), hemorrhagic risks, cancer therapy, immunotherapy, Immunologic diseases. Allergy, RC581-607

File Description: electronic resource

Relation: https://www.frontiersin.org/articles/10.3389/fimmu.2025.1527570/full; https://doaj.org/toc/1664-3224

Access URL: https://doaj.org/article/2986da899f194dd4902d7c53b1d49ba5

Cardiovascular adverse events associated with antibody-drug conjugates (ADCs): a pharmacovigilance study based on the FAERS database

Authors: PingPing Long, Siyu Li, Lingyun Pan, Yuanqiang Wang, Wanyi Chen, Xiaoxiao Wang

Source: Frontiers in Pharmacology, Vol 15 (2024)

Subject Terms: FAERS, disproportionality analysis, antibody-drug conjugate, cardiovascular toxicity, adverse events, Therapeutics. Pharmacology, RM1-950

File Description: electronic resource

Relation: https://www.frontiersin.org/articles/10.3389/fphar.2024.1378010/full; https://doaj.org/toc/1663-9812

Access URL: https://doaj.org/article/c5937ae11eb64635b8653b3fbef0905c

CD44-Targeted Facile Enzymatic Activatable Chitosan Nanoparticles for Efficient Antitumor Therapy and Reversal of Multidrug Resistance.

Authors: Xiaodong Zhang, Fan He, Keqi Xiang, Jiajing Zhang, Mingzhi Xu, Pingping Long, Haijia Su, Zhihua Gan, Qingsong Yu

Source: Biomacromolecules; 3/12/2018, Vol. 19 Issue 3, p883-895, 13p

On the Importance of Enhancing the Cultural and Educational Standards of Minority Nationalities in the Capital.

Authors: Heng, Wu, Pingping, Long

Source: Chinese Education & Society; Apr1989, Vol. 22 Issue 1, p76-91, 16p